The survival rate at 5 years in Turkish metastatic melanoma patients treated with ipilimumab: Final analysis of MIPI-TURK.

Alper Sevinc,Hande Turna,M. Ozdogan,Suleyman Buyukberber,Nil Molinas Mandel,Gokhan Demir,Erhan Gokmen,Semra Paydas,Hakan Akbulut,Ismail Celik

The survival rate at 5 years in Turkish metastatic melanoma patients treated with ipilimumab: Final analysis of MIPI-TURK.

2015

Alper Sevinc
Hande Turna
M. Ozdogan
Suleyman Buyukberber
Nil Molinas Mandel
Gokhan Demir
Erhan Gokmen
Semra Paydas
Hakan Akbulut
Ismail Celik

e20072 Survival rate at 5 years in Turkish metastatic melanoma patients treated with ipilimumab: final analysis of MIPI-TURK. Background: Ipilimumab has been shown to improve immune responses and o...

Keywords:

Oncology
Pathology
Melanoma
Ipilimumab
Turkish
Internal medicine
Survival rate
Medicine
metastatic melanoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations